To explore the clinical importance of Src as a marker for disease-free and overall survival, cytoplasmic Src expression was divided into high (above median; ≥4% positive tumor cells) and low (below median; <4% positive tumor cells) staining, whereas expression of total and phosphorylated Src at the plasma membrane and expression of phosphorylated Src in the cytoplasm were divided into negative (no staining) and positive (any staining). This evidence concerns the gene SRC and neoplasm.